论文信息 - bendamustine Plus Rituximab In First Line Systemic Treatment For Extranodal Malt Lymphoma: Final Results Of Phase Ii Trial Of The Spanish Lymphoma Study Group (geltamo) : 100 - 字舞流文

bendamustine Plus Rituximab In First Line Systemic Treatment For Extranodal Malt Lymphoma: Final Results Of Phase Ii Trial Of The Spanish Lymphoma Study Group (geltamo) : 100

A. Salar | J. Sancho | J. Bargay | L. Palomera | C. Montalbán | C. Panizo | E. Domingo-Domènech | C. Grande | R. Arranz | M. Canales | D. Caballero | M. Rodríguez | E. Conde | J. Peñalver | J. Tomás | J. Bello | J. J. Sanchez-blanco | C. Nicolás | A. Muntañola